Insider Trading activities of Nexvet Biopharma Plc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nexvet Biopharma Plc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nexvet Biopharma Plc since year 2005. Table 2 shows the detailed insider transactions of Nexvet Biopharma Plc since 2005. The reporting company's ticker symbol is NVET. The reporting company's CIK number is 1618561.
The total value of stock buying since 2005 is $4,085,036.
The total value of stock sales since 2005 is $431.
The total value of stock option exercises since 2005 is $45,544.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Nexvet Biopharma Plc (NVET).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-07 0 $0 0 $0 164,072 $20,507
2017-06 0 $0 0 $0 2,000 $248
2017-03 0 $0 0 $0 2,000 $248
2016-12 0 $0 0 $0 2,000 $248
2016-09 0 $0 0 $0 2,000 $248
2016-07 0 $0 0 $0 89,223 $11,169
2016-06 0 $0 0 $0 2,000 $248
2016-03 12,613 $41,838 132 $431 2,000 $248
2016-02 36,126 $119,300 0 $0 0 $0
2015-12 0 $0 0 $0 2,000 $248
2015-11 0 $0 0 $0 64,036 $8,002
2015-09 31,100 $173,898 0 $0 2,000 $248
2015-07 0 $0 0 $0 17,699 $2,211
2015-06 0 $0 0 $0 9,680 $1,209
2015-05 0 $0 0 $0 3,700 $462
2015-02 100,000 $1,000,000 0 $0 0 $0
2014-02 275,000 $2,750,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Nexvet Biopharma Plc insiders (NVET)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-07-01 Horn Jurgen (Chief Product Development Ofcr) Option Ex 15,750 .12 1,968
2017-07-01 Gunn George W (Director) Option Ex 3,600 .12 450
2017-07-01 Mccracken Joseph S (Director) Option Ex 3,600 .12 450
2017-07-01 Kilty Cormac G (Director) Option Ex 3,600 .12 450
2017-07-01 Heffernan Mark (Chief Executive Officer) Option Ex 60,643 .12 7,580
2017-07-01 Hanna Ashraf (Director) Option Ex 3,600 .12 450
2017-07-01 Brown Christopher Nigel (Director) Option Ex 3,600 .12 450
2017-07-01 Farrell Geraldine T (VP Operations, General Counsel) Option Ex 21,400 .12 2,675
2017-07-01 Payne John Bernard (Director) Option Ex 3,600 .12 450
2017-07-01 Lismore Damian T. (Chief Financial Officer) Option Ex 41,079 .12 5,134
2017-07-01 Patel Rajiv A Option Ex 3,600 .12 450
2017-06-30 Gunn George W (Director) Option Ex 500 .12 62
2017-06-30 Mccracken Joseph S (Director) Option Ex 500 .12 62
2017-06-30 Hanna Ashraf (Director) Option Ex 500 .12 62
2017-06-30 Patel Rajiv A Option Ex 500 .12 62
2017-03-31 Gunn George W (Director) Option Ex 500 .12 62
2017-03-31 Mccracken Joseph S (Director) Option Ex 500 .12 62
2017-03-31 Hanna Ashraf (Director) Option Ex 500 .12 62
2017-03-31 Patel Rajiv A Option Ex 500 .12 62
2016-12-31 Gunn George W (Director) Option Ex 500 .12 62
2016-12-31 Mccracken Joseph S (Director) Option Ex 500 .12 62
2016-12-31 Hanna Ashraf (Director) Option Ex 500 .12 62
2016-12-31 Patel Rajiv A Option Ex 500 .12 62
2016-09-30 Gunn George W (Director) Option Ex 500 .12 62
2016-09-30 Mccracken Joseph S (Director) Option Ex 500 .12 62
2016-09-30 Hanna Ashraf (Director) Option Ex 500 .12 62
2016-09-30 Patel Rajiv A Option Ex 500 .12 62
2016-07-01 Gunn George W (Director) Option Ex 3,600 .12 450
2016-07-01 Gearing David (Chief Scientific Officer) Option Ex 11,233 .12 1,404
2016-07-01 Mccracken Joseph S (Director) Option Ex 3,600 .12 450
2016-07-01 Kilty Cormac G (Director) Option Ex 3,600 .12 450
2016-07-01 Heffernan Mark (Chief Executive Officer) Option Ex 29,833 .12 3,729
2016-07-01 Hanna Ashraf (Director) Option Ex 3,600 .12 450
2016-07-01 Brown Christopher Nigel (Director) Option Ex 3,600 .13 468
2016-07-01 Farrell Geraldine T (VP Operations, General Counsel) Option Ex 5,207 .12 650
2016-07-01 Payne John Bernard (Director) Option Ex 3,600 .12 450
2016-07-01 Lismore Damian T. (Chief Financial Officer) Option Ex 17,750 .12 2,218
2016-07-01 Patel Rajiv A Option Ex 3,600 .12 450
2016-06-30 Gunn George W (Director) Option Ex 500 .12 62
2016-06-30 Mccracken Joseph S (Director) Option Ex 500 .12 62
2016-06-30 Hanna Ashraf (Director) Option Ex 500 .12 62
2016-06-30 Patel Rajiv A Option Ex 500 .12 62
2016-03-31 Gunn George W (Director) Option Ex 500 .12 62
2016-03-31 Mccracken Joseph S (Director) Option Ex 500 .12 62
2016-03-31 Hanna Ashraf (Director) Option Ex 500 .12 62
2016-03-31 Patel Rajiv A Option Ex 500 .12 62
2016-03-04 Gearing David (CHIEF SCIENTIFIC OFFICER) Buy 9,000 3.35 30,150
2016-03-03 Gearing David (CHIEF SCIENTIFIC OFFICER) Buy 2,113 3.26 6,888
2016-03-03 Farrell Geraldine T (VP Operations, General Counsel) Sale 132 3.27 431
2016-03-02 Hanna Ashraf (Director) Buy 1,500 3.20 4,800
2016-02-26 Gearing David (Chief Scientific Officer) Buy 12,126 3.34 40,500
2016-02-25 Gearing David (Chief Scientific Officer) Buy 19,000 3.30 62,700
2016-02-18 Lismore Damian T. (Chief Financial Officer) Buy 5,000 3.22 16,100
2015-12-31 Gunn George W (Director) Option Ex 500 .12 62
2015-12-31 Mccracken Joseph S (Director) Option Ex 500 .12 62
2015-12-31 Hanna Ashraf (Director) Option Ex 500 .12 62
2015-12-31 Patel Rajiv A Option Ex 500 .12 62
2015-11-23 Gearing David (Chief Scientific Officer) Option Ex 5,600 .12 700
2015-11-23 Heffernan Mark (Chief Executive Officer) Option Ex 7,250 .12 906
2015-11-23 Farrell Geraldine T (VP Operations, General Counsel) Option Ex 4,300 .12 537
2015-11-23 Lismore Damian T. (CHIEF FINANCIAL OFFICER) Option Ex 6,000 .12 750
2015-11-20 Heffernan Mark (Chief Executive Officer) Option Ex 9,204 .12 1,150
2015-11-17 Lismore Damian T. (Chief Financial Officer) Option Ex 7,080 .12 885
2015-11-07 Gearing David (Chief Scientific Officer) Option Ex 9,203 .12 1,150
2015-11-05 Gearing David (Chief Scientific Officer) Option Ex 9,204 .12 1,150
2015-11-05 Farrell Geraldine T (VP Operations, General Counsel) Option Ex 6,195 .12 774
2015-09-30 Gunn George W (Director) Option Ex 500 .12 62
2015-09-30 Mccracken Joseph S (Director) Option Ex 500 .12 62
2015-09-30 Hanna Ashraf (Director) Option Ex 500 .12 62
2015-09-30 Patel Rajiv A Option Ex 500 .12 62
2015-09-10 Spokes Andrew J M Buy 10,800 6.48 69,984
2015-09-09 Gunn George W (Director) Buy 10,000 5.43 54,330
2015-09-09 Kilty Cormac G (Director) Buy 10,000 4.79 47,859
2015-09-09 Spokes Andrew J M Buy 300 5.75 1,725
2015-07-15 Wald Graeme (Director) Option Ex 3,600 .12 450
2015-07-13 Gunn George W (Director) Option Ex 1,400 .12 175
2015-07-01 Giles Colin (VP Clinical&Regulatory Affairs) Option Ex 2,098 .12 262
2015-07-01 Gearing David (CHIEF SCIENTIFIC OFFICER) Option Ex 3,734 .12 466
2015-07-01 Farrell Geraldine T (VP Operations, General Counsel) Option Ex 2,867 .12 358
2015-07-01 Lismore Damian T. (CHIEF FINANCIAL OFFICER) Option Ex 4,000 .12 500
2015-06-30 Mccracken Joseph S (Director) Option Ex 1,400 .12 175
2015-06-30 Kilty Cormac G (Director) Option Ex 3,600 .12 450
2015-06-30 Hanna Ashraf (Director) Option Ex 1,400 .12 175
2015-06-30 Payne John Bernard (Director) Option Ex 900 .12 112
2015-06-30 Patel Rajiv A Option Ex 1,400 .12 175
2015-06-15 Patel Rajiv A Option Ex 980 .12 122
2015-05-18 Mccracken Joseph S (Director) Option Ex 1,400 .12 175
2015-05-18 Hanna Ashraf (Director) Option Ex 1,400 .12 175
2015-05-18 Payne John Bernard (Director) Option Ex 900 .12 112
2015-02-10 One Funds Management Ltd Atf Asia Pacific Healthcare Fund Ii (10% Owner) Buy 100,000 10.00 1,000,000
2014-02-10 Gross Phillip Buy 275,000 10.00 2,750,000

Insider trading activities including stock purchases, stock sales, and option exercises of NVET listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nexvet Biopharma Plc (symbol NVET, CIK number 1618561) see the Securities and Exchange Commission (SEC) website.